OT Breast Cancer

Coverage from

2018 ASCO Annual Meeting

Focus on Breast Cancer


Featured Content

Hear the latest on breast cancer trends straight from the experts.



Exciting Developments

Megan Kruse, MD, department of Hematology and Medical Oncology, Cleveland Clinic, is encouraged by today’s new breast cancer treatment options.

Test Spares Extended Endocrine Therapy in Low-Risk ER+ Breast Cancer

A gene test that predicts relapse in women with ER+ early breast cancer can identify patients with low-risk disease who could safely avoid extending their endocrine therapy beyond the standard 5 years, according to study findings reported in a poster session at the 2018 ASCO Annual Meeting.




Listen to Dennis J. Slamon, MD, PhD, director of Clinical/Translational Research; director of the Revlon/UCLA Women's Cancer Research Program at Jonsson Comprehensive Cancer Center; and executive vice chair for Research for UCLA's Department of Medicine discuss results from the MONALEESA-3.